145 related articles for article (PubMed ID: 36118075)
1. Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature review.
Kokabu T; Aoyama K; Tarumi Y; Kataoka H; Yoriki K; Mori T
Gynecol Oncol Rep; 2022 Oct; 43():101065. PubMed ID: 36118075
[TBL] [Abstract][Full Text] [Related]
2. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions.
Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM
Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of hypersensitivity reaction of platinum in ovarian cancer and cervical cancer patients].
Li L; Wu M; Yang JX; Wan XR; Huang HF; Pan LY; Shen K; Lang JH; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):825-831. PubMed ID: 27916065
[No Abstract] [Full Text] [Related]
4. Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study.
Paksoy N; Khanmammadov N; Doğan İ; Ferhatoğlu F; Yildiz A; Ak N; Aydiner A
Medicine (Baltimore); 2022 Nov; 101(45):e31726. PubMed ID: 36397338
[TBL] [Abstract][Full Text] [Related]
5. Retreatment with nedaplatin in patients with recurrent gynecological cancer after the development of hypersensitivity reaction to carboplatin.
Arimoto T; Oda K; Nakagawa S; Kawana K; Tsukazaki T; Adachi K; Matsumoto Y; Yano T; Kozuma S; Taketani Y
J Obstet Gynaecol Res; 2013 Jan; 39(1):336-40. PubMed ID: 22690725
[TBL] [Abstract][Full Text] [Related]
6. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies.
Michikami H; Minaguchi T; Ochi H; Onuki M; Okada S; Matsumoto K; Satoh T; Oki A; Yoshikawa H
J Obstet Gynaecol Res; 2013 Jan; 39(1):330-5. PubMed ID: 22640034
[TBL] [Abstract][Full Text] [Related]
8. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S
Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases.
Itoh K; Yamashita T; Wakita H; Watanabe Y; Kodama K; Fujii H; Minami H; Ohtsu T; Igarashi T; Sasaki Y
Jpn J Clin Oncol; 1998 May; 28(5):343-6. PubMed ID: 9703864
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
[TBL] [Abstract][Full Text] [Related]
11. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
[TBL] [Abstract][Full Text] [Related]
12. Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer.
Ge L; Li N; Yuan GW; Sun YC; Wu LY
Am J Cancer Res; 2018; 8(6):1074-1082. PubMed ID: 30034944
[TBL] [Abstract][Full Text] [Related]
13. 4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study.
Nishimura M; Sakai H; Onoe T; Boku S; Yokoyama T; Kadokura G; Morita S; Katsumata N; Matsumoto K
Int J Clin Oncol; 2021 Aug; 26(8):1553-1560. PubMed ID: 34037884
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
[TBL] [Abstract][Full Text] [Related]
15. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers.
Zwimpfer TA; Scherer K; Schötzau A; Heinzelmann-Schwarz V; Hartmann K; Vetter M; Montavon C
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38140783
[TBL] [Abstract][Full Text] [Related]
16. Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports.
Soeda S; Watanabe T; Kamo N; Sato T; Okabe C; Ueda M; Endo Y; Manabu K; Nomura S; Furukawa S; Nishigori H; Takahashi T; Fujimori K
Anticancer Res; 2020 Sep; 40(9):5263-5270. PubMed ID: 32878815
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of desensitization protocol for a carboplatin hypersensitivity reaction during docetaxel-carboplatin therapy for recurrent ovarian cancer: Case report.
Shoji T; Takatori E; Kaido Y; Kumagai S; Takeuchi S; Yoshizaki A; Sugiyama T
Oncol Lett; 2010 Nov; 1(6):1021-1023. PubMed ID: 22870105
[TBL] [Abstract][Full Text] [Related]
18. Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancer.
Toyohara Y; Sone K; Nishida H; Taguchi A; Miyamoto Y; Tanikawa M; Mori M; Tsuruga T; Matsumoto Y; Oda K; Osuga Y; Fujii T
J Obstet Gynaecol Res; 2020 Nov; 46(11):2298-2304. PubMed ID: 32830407
[TBL] [Abstract][Full Text] [Related]
19. [Successful desensitization protocol for patients with hypersensitivity reactions caused by carboplatin].
Nishio S; Koyanagi T; Miyabe K; Kuromatsu H
Gan To Kagaku Ryoho; 2010 Apr; 37(4):731-3. PubMed ID: 20414037
[TBL] [Abstract][Full Text] [Related]
20. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
